Done sou Salè H1B

Akèy › Kat vèt › Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc.: sponso kat vèt (PERM)

Allogene Therapeutics, Inc. te depoze 4 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 3. Mwayèn salè yo ofri $135,000; mwayèn tan soti nan depozisyon jiska sètifikasyon: 471 jou.

Aplikasyon PERM4
Sètifye3
Salè medyan ofri$135,000
Mwayèn jou pou sètifikasyon471
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)360
Nan biznis depi2018
Adrès anplwayèSouth San Francisco, CA

Salè H-1B nan Allogene Therapeutics, Inc. →

Tit travay

Tit travayAplikasyon PERMSalè medyan
Scientist, Process Development1$115,000
Scientist1$135,000
Senior Clinical Trial Manager1$189,000
Scientist, Cell Engineering1—

Kote travay

Okipasyon

Dènye desizyon

Tit travaySalè bazKoteSoumètDesideEstatiJou
Senior Clinical Trial Manager$189,000–$210,000South San Francisco, CANov 13, 2024Mar 25, 2026Sètifye497
Scientist$135,000–$155,000South San Francisco, CAOct 24, 2023Feb 5, 2025Sètifye, ekspiré470
Scientist, Process Development$115,000–$135,000South San Francisco, CAOct 23, 2023Feb 5, 2025Sètifye, ekspiré471
Scientist, Cell Engineering$115,000–$135,000South San Francisco, CAOct 23, 2023Mar 19, 2024Retire—

Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).